Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph A. Pidala, Samantha Jaglowski, Marcello Rotta et al.|Blood Advances|2024Cited by 16
Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic TransplantationNelli Bejanyan, Marco L. Davila, Hany Elmariah et al.|Blood|2024Cited by 2
De Novo Resistance and Relapse from Daratumumab Monotherapy in NDMM Is Associated with Immune Evasion and ImmunosuppressionMark B. Meads, Kenneth H. Shain, Xiaohong Zhao et al.|Blood|2024Cited by 1
Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic TransplantationNelli Bejanyan, Marco L. Davila, Hany Elmariah et al.|Transplantation and Cellular Therapy|2025Cited by 1